Literature DB >> 7918089

An atypical myeloproliferative disorder with t(8;13) (p11;q12): a third case.

D Macdonald1, S M Sheerin, N C Cross, A Spencer, J M Goldman.   

Abstract

A 43-year-old male presented with a myeloproliferative disorder with prominent lymphadenopathy. Examination of the bone marrow showed almost complete replacement by a population of cells with an acquired chromosomal translocation t(8;13)(p11;q12). There are two other case reports describing a similar clinical syndrome with t(8;13)(p11;q12) as the sole chromosomal aberration in bone marrow cells, suggesting a role for this translocation in the pathogenesis of this myeloproliferative disorder.

Entities:  

Mesh:

Year:  1994        PMID: 7918089     DOI: 10.1111/j.1365-2141.1994.tb04848.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.

Authors:  Chitta S Kasyapa; Padmaja Kunapuli; Lesleyann Hawthorn; John K Cowell
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

Review 2.  [The 8p11 myeloproliferative syndrome].

Authors:  A Reither; R Hehlmann; J M Goldman; N C Cross
Journal:  Med Klin (Munich)       Date:  1999-04-15

3.  Myeloproliferative Syndrome With Eosinophilia Associated With Translocation t(8; 13) and T-cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature.

Authors:  Lizeth Yamile Urrea Pineda; Oliver Perilla; Vanessa Santiago-Pacheco; Simon Trujillo Montoya
Journal:  Cureus       Date:  2022-03-01

4.  The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.

Authors:  Ami Goradia; Michael Bayerl; Dennis Cornfield
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.